JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5201
Pacer Trendpilot US Large Cap ETF
PTLC
$3.35B
| $25K | ﹤0.01% |
824
-57,498
| -99% | -$1.72M |
2018 Q4
2 quarters
|
|
5202
Mammoth Energy Services
TUSK
$134M
| $25K | ﹤0.01% |
3,570
+519
| +17% | +$6.59K |
2016 Q4
10 quarters
|
|
5203
US Commodity Index
USCI
$414M
| $25K | ﹤0.01% |
650
+150
| +30% | +$5.66K |
2018 Q2
4 quarters
|
|
5204
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$352M
| $25K | ﹤0.01% |
270
| – | – |
2016 Q2
12 quarters
|
|
|
VBIV
5205
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $25K | ﹤0.01% |
+768
| New | +$41.6K |
2019 Q2
0 quarters
|
|
|
SRRA
5206
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $25K | ﹤0.01% |
1,093
+992
| +982% | +$48K |
2019 Q1
1 quarter
|
|
|
ISRL
5207
DELISTED
Isramco Inc
ISRL
| $25K | ﹤0.01% |
203
+22
| +12% | +$2.6K |
2017 Q4
6 quarters
|
|
5208
PUT
Campbell Soup
CPB
$5.82B
| $24K | ﹤0.01% |
+600
| New | +$23.6K |
2019 Q2
0 quarters
|
|
5209
Invesco DB Oil Fund
DBO
$284M
| $24K | ﹤0.01% |
+2,353
| New | +$24.4K |
2019 Q2
0 quarters
|
|
5210
Vitamin Cottage Natural Grocers
NGVC
$684M
| $24K | ﹤0.01% |
2,490
-1,691
| -40% | -$19.4K |
2017 Q3
7 quarters
|
|
|
STRM
5211
DELISTED
Streamline Health Solutions
STRM
| $24K | ﹤0.01% |
+883
| New | +$17K |
2019 Q2
0 quarters
|
|
5212
Schwab US Mid-Cap ETF
SCHM
$14.5B
| $23K | ﹤0.01% |
+1,209
| New | +$22.6K |
2019 Q2
0 quarters
|
|
5213
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$11M
| $23K | ﹤0.01% |
2,000
| – | – |
2018 Q4
2 quarters
|
|
5214
AYTU BioPharma
AYTU
$22.4M
| $22K | ﹤0.01% |
+62
| New | +$23.6K |
2019 Q2
0 quarters
|
|
5215
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.32B
| $22K | ﹤0.01% |
209
| – | – |
2019 Q1
1 quarter
|
|
5216
Gaia
GAIA
$35.6M
| $22K | ﹤0.01% |
2,886
-20
| -0.7% | -$168 |
2017 Q4
6 quarters
|
|
5217
Invesco Value Municipal Income Trust
IIM
$507M
| $22K | ﹤0.01% |
1,442
-74,972
| -98% | -$1.1M |
2019 Q1
1 quarter
|
|
5218
Nuveen California Quality Municipal Income Fund
NAC
$1.57B
| $22K | ﹤0.01% |
1,536
| – | – |
2018 Q4
2 quarters
|
|
5219
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3B
| $22K | ﹤0.01% |
1,566
-48,421
| -97% | -$651K |
2018 Q4
2 quarters
|
|
5220
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.26B
| $22K | ﹤0.01% |
1,413
| – | – |
2018 Q4
2 quarters
|
|
5221
Organogenesis Holdings
ORGO
$170M
| $22K | ﹤0.01% |
2,894
+2,094
| +262% | +$15.4K |
2019 Q1
1 quarter
|
|
|
JPT
5222
DELISTED
Nuveen Preferred and Income Fund
JPT
| $22K | ﹤0.01% |
894
| – | – |
2018 Q4
2 quarters
|
|
|
PTE
5223
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $22K | ﹤0.01% |
154
+56
| +57% | +$10.6K |
2018 Q2
4 quarters
|
|
|
TRQ
5224
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $22K | ﹤0.01% |
1,790
-141
| -7% | -$1.95K |
2013 Q2
24 quarters
|
|
|
CKPT
5225
DELISTED
Checkpoint Therapeutics
CKPT
| $21K | ﹤0.01% |
+633
| New | +$24.8K |
2019 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.